Evaluation of the Safety and Performance Characteristics of Mesofiller Mesotox for the Correction of Wrinkles and Rehydration of the Face.

NACompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

November 15, 2022

Primary Completion Date

July 5, 2023

Study Completion Date

July 5, 2023

Conditions
Skin AgingSkin Wrinkling
Interventions
DEVICE

mesofiller® mesotox

The investigated product mesofiller® mesotox was applied by intradermal or subcutaneous injection by the investigator during Session 1 for all subjects and Session 2 for the subjects, for whom a touch-up was considered beneficial. Both sessions were conducted within 14-day intervals.

Trial Locations (1)

1000

"Medical Center Ramus EOOD", Sofia

All Listed Sponsors
lead

Mesoestetic Pharma Group S.L.

INDUSTRY